Apr 28, 2024, 05:14
Aleix Prat: Our new article about attitudes towards HER2DX in Spain
Aleix Prat, Director of the Cancer Institute at Hospital Clinic of Barcelona, shared on X/Twitter:
“Our new article is out, led by Olga Martínez-Sáez! Management of early-stage HER2+ breast cancer and attitudes towards HER2DX in Spain.
An online questionnaire was conducted by an independent third-party across 70 medical oncologists highly specialized in breast cancer in Spain. Conclusions:
- A notable diversity in therapeutic approaches was observed in the same clinical scenario
- The majority acknowledged HER2DX as a clinically valuable test for specific patients”
Further reading.
Source: Aleix Prat/X